Back
Colgate-Palmolive Vs. Tandem Diabetes Care Industry Stock Comparison
Buy
64
CL
Colgate-Palmolive
Last Price:
93.74
Seasonality Move:
0.25%
Buy
75
TNDM
Tandem Diabetes Care
Last Price:
49.68
Seasonality Move:
17.33%
Buy
64
Colgate-Palmolive (CL)
is a Buy
Is Colgate-Palmolive a Buy, Sell or Hold?
- The current Colgate-Palmolive [CL] share price is $94.76. The Score for CL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- CL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Tandem Diabetes Care (TNDM)
is a Buy
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $51.39. The Score for TNDM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- TNDM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CL Stock Price Chart
What is Colgate-Palmolive's stock price today?
-
The Colgate-Palmolive share price today is $94.76
The current trend is moderately bullish and CL is experiencing slight selling pressure.
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $51.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNDM is experiencing slight buying pressure.
CL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.55 | Buy |
| Relative Strength Index (14 RSI): | 68.58 | Buy |
| Chaikin Money Flow: | -472658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (89.63 - 94.89) | Buy |
| Bollinger Bands (100): | (82.58 - 91.2) | Buy |
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.93 | Buy |
| Relative Strength Index (14 RSI): | 78.86 | Buy |
| Chaikin Money Flow: | 156222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.8 - 46.86) | Buy |
| Bollinger Bands (100): | (24.01 - 38.39) | Buy |
CL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.57 | Buy |
| 20-day SMA: | 93.34 | Buy |
| 50-day SMA: | 90.15 | Buy |
| 200-day SMA: | 80.74 | Buy |
| 8-day EMA: | 94.47 | Buy |
| 20-day EMA: | 93.16 | Buy |
| 50-day EMA: | 90.5 | Buy |
| 200-day EMA: | 83.45 | Buy |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.19 | Buy |
| 20-day SMA: | 42.88 | Buy |
| 50-day SMA: | 36.65 | Buy |
| 200-day SMA: | 26.81 | Buy |
| 8-day EMA: | 47.52 | Buy |
| 20-day EMA: | 43.6 | Buy |
| 50-day EMA: | 37.98 | Buy |
| 200-day EMA: | 31.5 | Buy |
Colgate-Palmolive Earnings Growth & CL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.07 per share, an increase this year of $0.31 per share, and an increase next year of $0.31 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.15 per share, and an increase next year of $0.54 per share.
Colgate-Palmolive Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tandem Diabetes Care Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||